• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and Examination of Chemical APIs
Saturday, 26 February 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

Acceptance and Examination of Chemical APIs – Trial Guidelines (Draft) Issued

Acceptance and examination of chemical APIs trial guidelines have had its first draft issued in April 2020. The trial guideline is expected to be finalized and come into effect soon. The guideline will improve the precision in preparing the dossier and reduce the time needed for the application.

On February 8, 2022, the CDE (Centre for Drug Evaluation) issued the second draft to supplement the Administrative Measures for Drug Registration (No.27-2020).

Highlights – Acceptance and examination of chemical APIs

  • The scope is adjusted to be applicable for the registration of APIs only.
  • Added supporting document requirements in terms of product design validation, product registration number, etc.
  • Standardized format and size of the CD-Rom for submission and facilitation of data management.

By Yu Fang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Active Pharmaceutical Ingredients, API, drug, pharmaceuticals

What you can read next

pre-phase III drug clinical trial meeting guidelines
Pre-phase III drug clinical trial meeting guidelines released
Technical guideline for children's cosmetics
Technical Guideline for Children’s Cosmetics in China (Draft)
NMPA Major Updates Concerning IVDs

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP